These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 7276648

  • 1. [Studies on the appropriate frequency of the cervical cancer screening (author's transl)].
    Hando T, Kodama S, Obata N, Goto A, Takeuchi S, Aoki S.
    Nihon Sanka Fujinka Gakkai Zasshi; 1981 Aug; 33(8):1205-8. PubMed ID: 7276648
    [Abstract] [Full Text] [Related]

  • 2. Risk of invasive cervical cancer after Pap smears: the protective effect of multiple negatives.
    Coldman A, Phillips N, Kan L, Matisic J, Benedet L, Towers L.
    J Med Screen; 2005 Aug; 12(1):7-11. PubMed ID: 15814014
    [Abstract] [Full Text] [Related]

  • 3. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
    Andrae B, Kemetli L, Sparén P, Silfverdal L, Strander B, Ryd W, Dillner J, Törnberg S.
    J Natl Cancer Inst; 2008 May 07; 100(9):622-9. PubMed ID: 18445828
    [Abstract] [Full Text] [Related]

  • 4. [A result of mass-screening for uterine cervical cancer in Hyogo prefecture (author's transl)].
    Hasegawa K, Miyazaki Y, Kitaura Y, Ohtsu F, Takeuchi K.
    Nihon Sanka Fujinka Gakkai Zasshi; 1981 Dec 07; 33(12):2097-104. PubMed ID: 7338662
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Appropriate frequency of mass-screening for uterine cervical cancer.
    Iwanari O.
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Oct 07; 39(10):1799-805. PubMed ID: 3429977
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Differences in screening history, tumour characteristics and survival between women with screen-detected versus not screen-detected cervical cancer in the east of The Netherlands, 1992-2001.
    van der Aa MA, Schutter EM, Looijen-Salamon M, Martens JE, Siesling S.
    Eur J Obstet Gynecol Reprod Biol; 2008 Aug 07; 139(2):204-9. PubMed ID: 18093720
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The pap-smear history of women with invasive cervical squamous carcinoma. A case-control study from Sweden.
    Andersson-Ellström A, Seidal T, Grannas M, Hagmar B.
    Acta Obstet Gynecol Scand; 2000 Mar 07; 79(3):221-6. PubMed ID: 10716304
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Studies on the appropriated interval of mass screening for cervical cancer].
    Kusanagi T, Kudo R, Ito E, Sagae S, Hori Y, Tamura H, Hayakawa O, Fujimura Y, Hashimoto M.
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Jun 07; 35(6):782-6. PubMed ID: 6875333
    [Abstract] [Full Text] [Related]

  • 14. Pap test--with or without vaginal smear?
    Milicić-Juhas V, Perić M, Pajtler M, Prvulović I, Curzik D.
    Coll Antropol; 2010 Mar 07; 34(1):69-74. PubMed ID: 20437636
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Optimal frequency of screening for cervical cancer: a Toronto case-control study.
    Clarke EA, Hilditch S, Anderson TW.
    IARC Sci Publ; 1986 Mar 07; (76):125-31. PubMed ID: 3570399
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A longitudinal Swedish study on screening for squamous cell carcinoma and adenocarcinoma: evidence of effectiveness and overtreatment.
    Gunnell AS, Ylitalo N, Sandin S, Sparén P, Adami HO, Ripatti S.
    Cancer Epidemiol Biomarkers Prev; 2007 Dec 07; 16(12):2641-8. PubMed ID: 18086769
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.